Hydramine and Atomoxetine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydramine (diphenhydramine hydrochloride) and Atomoxetine (atomoxetine). Common drug interactions include psoriatic arthropathy among females and completed suicide among males.

The phase IV clinical study analyzes what interactions people have when they take Hydramine and Atomoxetine. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Atomoxetine?

Atomoxetine has active ingredients of atomoxetine. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,363 Atomoxetine users. Check the latest studies of Atomoxetine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

72 people who take Hydramine and Atomoxetine together, and have interactions are studied.

Hydramine and Atomoxetine drug interactions.

What are the common drug interactions of Hydramine and Atomoxetine, by gender? *:

female:

  1. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  4. Scar
  5. Seasonal allergy (allergic condition due to certain season)
  6. Sinusitis (inflammation of sinus)
  7. Swelling
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Cardiac arrest
  10. Completed suicide (act of taking one's own life)

male:

  1. Completed suicide (act of taking one's own life)
  2. Cardiac arrest
  3. Irritability
  4. Dyspnoea (difficult or laboured respiration)
  5. Oxygen saturation decreased
  6. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  7. Anaemia (lack of blood)
  8. Gastric varices
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Haematemesis (vomiting of blood)

What are the common drug interactions of Hydramine and Atomoxetine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Overdose
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Cardiac arrest
  4. Completed suicide (act of taking one's own life)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Liver injury
  7. Myocarditis (inflammation of heart muscle myocardium)
  8. Dizziness
  9. Electrocardiogram qt prolonged
  10. Headache (pain in head)

20-29:

  1. Completed suicide (act of taking one's own life)
  2. Cardiac arrest
  3. Atrioventricular block (heart block)
  4. Bradycardia (abnormally slow heart action)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Hypotension (abnormally low blood pressure)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Dyspnoea (difficult or laboured respiration)
  9. Oxygen saturation decreased
  10. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)

30-39:

n/a

40-49:

  1. Ear pain
  2. Fatigue (feeling of tiredness)
  3. Feeling jittery
  4. Headache (pain in head)
  5. Infusion related reaction
  6. Poor venous access
  7. Rhinorrhoea (watery mucus discharge from the nose)
  8. Muscular weakness (muscle weakness)
  9. Nasopharyngitis (inflammation of the nasopharynx)

50-59:

  1. Blepharitis (chronic inflammation of the eyelid)
  2. Eye infection
  3. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  4. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  5. Eyelid infection
  6. Staphylococcal infection (an infection with staphylococcus bacteria)
  7. Fall
  8. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  9. Weight decreased
  10. Infection

60+:

n/a

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 13 people, 18.06%
  2. Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 6.94%
  3. Rickets (softening of bones): 5 people, 6.94%
  4. Itching: 5 people, 6.94%
  5. Autoimmune Hepatitis: 5 people, 6.94%
  6. Viral Skin Infection: 4 people, 5.56%
  7. Sleep Disorder: 4 people, 5.56%
  8. Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and Atomoxetine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydramine and Atomoxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atomoxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydramine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atomoxetine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and atomoxetine (the active ingredients of Hydramine and Atomoxetine, respectively), and Hydramine and Atomoxetine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: